Fast Market Research recommends "MDxHealth SA (MDXH) - Product Pipeline Analysis, 2013 Update" from GlobalData, now available

Boston, MA -- (SBWire) -- 11/28/2013 --MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. It develops and commercializes advanced molecular diagnostic tests for the early detection of cancer and personalized treatment decisions. It focuses on three different types of cancers, namely, prostate cancer, colorectal cancer and lung cancer. The company's tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indications of cancer recurrence and prediction of response to a specific therapy. The company's product line includes molecular diagnostics, clinical diagnostics, and pharmaco diagnostics. It also offers biomarker development services to many pharmaceutical companies. The company has operations in Belgium and the US. MdxHealth is headquartered in Liege, Belgium.

The company envisages the provision of high value MDx products for use in the diagnosis and prognosis of cancers. It aims to develop and commercialize cancer diagnostic products for personalized cancer treatment with focus on prostate, colon, brain and lung cancers.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the MDxHealth SA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- MDxHealth SA (MDXH) - Product Pipeline Analysis
- Cepheid (CPHD) - Product Pipeline Analysis, 2013 Update
- FK-Biotecnologia SA - Product Pipeline Analysis, 2013 Update
- AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Medtronic, Inc. (MDT) - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- SANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis, 2013 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2013 Update